注射液
- Diagnosis and Treatment Protocol for Coronavirus Disease 2019(Trial Version 7)
on (喜炎平注射液), Xuebijing Injection (血必凈注射液), Reduning Injection (熱毒寧注射液), Tanreqing Injection (痰熱清注射液),and Xingnaojing Injection (醒腦靜注射液).Drugs with similar effects can be selected according to individual conditions, or can be used
World Journal of Integrated Traditional and Western Medicine 2020年5期2020-12-29
- Effects of Shenmai Injection (參麥注射液) Combined with Meglumine Adenosine Cyclophosphate Injection on Cardiac Function and Peripheral Serum Levels of TNF-α,TGF-β1 and IFN-γ in Patients with Viral Myocarditis
ion (參麥注射液) combined with Meglumine Adenosine Cyclophosphate Injection on cardiac function and peripheral serum levels of tumor necrosis factor-α (TNF-α), transforming growth factor-β1 (TGF-β1) and interferon-γ (IFN-γ) in patients
World Journal of Integrated Traditional and Western Medicine 2020年1期2020-02-20
- 舒血寧注射液與五種注射液配伍后的穩(wěn)定性考察
黃紅雯舒血寧注射液與五種注射液配伍后的穩(wěn)定性考察王偉洪 黃紅雯目的 考察舒血寧注射液與葡萄糖注射液(5%和10%兩種)、葡萄糖氯化鈉注射液(5%),氯化鈉注射液(0.9%)和復(fù)方氯化鈉注射液等五種注射液配伍后的穩(wěn)定性, 以及混合液放置時(shí)間與藥物穩(wěn)定性的關(guān)系。方法 參照臨床用藥一般濃度, 使用一次性滅菌注射器在五種注射液中分別加入舒血寧注射液, 劑量為20 ml, 搖勻后倒置；藥物滴注時(shí)間為2 h, 設(shè)置0 、15、30 min, 1.0、1.5、2.0
中國現(xiàn)代藥物應(yīng)用 2015年13期2015-05-06